Clinical Trial Update: COVID-19: Human Epidemiology and Response to SARS-CoV-2

View source ↗

Summary

A completed clinical trial update from NIAID examining COVID-19 epidemiology and the immune response to SARS-CoV-2, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Coronavirus Disease 2019 (COVID-19), SARS-CoV-2 | Status: COMPLETED | Results posted: 2023-12-05